228 related articles for article (PubMed ID: 25515765)
1. Sustained improvement in urticaria pigmentosa and pruritus in a case of indolent systemic mastocytosis treated with cladribine.
Lock AD; McNamara CJ; Rustin MH
Clin Exp Dermatol; 2015 Mar; 40(2):142-5. PubMed ID: 25515765
[TBL] [Abstract][Full Text] [Related]
2. ["Smoldering systemic mastocytosis. "Successful therapy with cladribine].
Schleyer V; Meyer S; Landthaler M; Szeimies RM
Hautarzt; 2004 Jul; 55(7):658-62. PubMed ID: 15241520
[TBL] [Abstract][Full Text] [Related]
3. Systemic mastocytosis: current concepts and treatment advances.
Tefferi A; Pardanani A
Curr Hematol Rep; 2004 May; 3(3):197-202. PubMed ID: 15087068
[TBL] [Abstract][Full Text] [Related]
4. Response of urticaria pigmentosa to cladribine in a patient with systemic mastocytosis.
Bennett M; Chubar Y
Br J Haematol; 2013 Feb; 160(4):420. PubMed ID: 23205635
[No Abstract] [Full Text] [Related]
5. [Vulvar oedema revealing systemic mastocytosis].
Deveza E; Locatelli F; Girardin M; Valmary-Degano S; Daguindau E; Aubin F; Humbert P; Pelletier F
Ann Dermatol Venereol; 2015 Nov; 142(11):685-9. PubMed ID: 26003033
[TBL] [Abstract][Full Text] [Related]
6. Response to cladribine in patient with systemic mastocytosis.
Radojković M; Ristić S; Colović N; Terzić T; Colović M
Vojnosanit Pregl; 2011 May; 68(5):444-6. PubMed ID: 21739912
[TBL] [Abstract][Full Text] [Related]
7. Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases.
Tefferi A; Kittur J; Farrukh F; Begna KH; Patnaik MM; Al-Kali A; Elliott MA; Reichard KK; Gangat N; Pardanani A
Br J Haematol; 2022 Feb; 196(4):975-983. PubMed ID: 34729775
[TBL] [Abstract][Full Text] [Related]
8. Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report.
Agarwala MK; George R; Mathews V; Balasubramanian P; Thomas M; Nair S
J Dermatolog Treat; 2013 Dec; 24(6):481-3. PubMed ID: 23659595
[TBL] [Abstract][Full Text] [Related]
9. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2015 Mar; 90(3):250-62. PubMed ID: 25688753
[TBL] [Abstract][Full Text] [Related]
10. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.
Böhm A; Sonneck K; Gleixner KV; Schuch K; Pickl WF; Blatt K; Peter B; Herrmann H; Schernthaner GH; Pehamberger H; Rabitsch W; Sperr WR; Valent P
Exp Hematol; 2010 Sep; 38(9):744-55. PubMed ID: 20553795
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
Hahn HP; Hornick JL
Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
[TBL] [Abstract][Full Text] [Related]
13. Cladribine therapy for systemic mastocytosis.
Kluin-Nelemans HC; Oldhoff JM; Van Doormaal JJ; Van 't Wout JW; Verhoef G; Gerrits WB; van Dobbenburgh OA; Pasmans SG; Fijnheer R
Blood; 2003 Dec; 102(13):4270-6. PubMed ID: 12933573
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis.
Godt O; Proksch E; Streit V; Christophers E
Dermatology; 1997; 195(1):35-9. PubMed ID: 9267734
[TBL] [Abstract][Full Text] [Related]
15. Progressive multifocal leukoencephalopathy in a patient with systemic mastocytosis treated with cladribine.
Alstadhaug KB; Fykse Halstensen R; Odeh F
J Clin Virol; 2017 Mar; 88():17-20. PubMed ID: 28095350
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
17. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
Hollmann TJ; Brenn T; Hornick JL
Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
[TBL] [Abstract][Full Text] [Related]
18. [Sudden death in the presence of systemic mastocytosis and urticaria pigmentosa].
Wehner F; Wehner HD; Fritz P; Benz D; Schulz MM
Arch Kriminol; 2008; 222(5-6):187-94. PubMed ID: 19216369
[TBL] [Abstract][Full Text] [Related]
19. Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis.
Aichberger KJ; Sperr WR; Gleixner KV; Kretschmer A; Valent P
Eur J Clin Invest; 2008 Nov; 38(11):869-73. PubMed ID: 19021706
[TBL] [Abstract][Full Text] [Related]
20. Maculopapular Cutaneous Mastocytosis Successfully Treated with Omalizumab.
Tampouratzi L; Kanni T; Katsantonis J; Douvali T
Acta Dermatovenerol Croat; 2021 Apr; 291(1):60-61. PubMed ID: 34477069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
